Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryAcarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomesCirculating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin.Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB.Postprandial platelet activation is related to postprandial plasma insulin rather than glucose in patients with type 2 diabetes.Platelet function in the postprandial periodAnalysis of the add-on effect of α-glucosidase inhibitor, acarbose in insulin therapy: A pilot studyOn the potential of acarbose to reduce cardiovascular disease.Control of postprandial glucose levels with insulin in type 2 diabetes.Platelet activation in obesity and metabolic syndrome.Overcoming aspirin treatment failure in diabetes.Metabolic Burden and Disease and Mortality Risk Associated with Impaired Fasting Glucose in Elderly Adults.Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemiaHaemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension.Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes.Platelets and diabetes: a complex association.
P2860
Q22241786-EBBDB559-F64E-474C-9994-D591D30057ACQ26778095-60BC2858-BA3E-4417-A652-1AB713A572C5Q35026334-6C0CDD6B-71D1-428F-AFBD-0013B5917F67Q35047406-6C7B0C49-EFB4-4F01-9E3D-5B21C72331C2Q35485016-31D21F1B-9273-4342-9096-AB75C02C7120Q35527857-765B9D4B-91A8-46A8-A7C4-687E99365918Q36182535-67DD9F97-E067-42EB-8F34-374CC46EF80AQ36411981-25951BDF-4BEB-43E8-8214-8D8AA122C637Q37289297-3B4B2333-B969-4D4C-83EA-335ADF4766B6Q37717838-3E7DCD12-4E43-4578-AAAF-39143F65D7F0Q37890790-95AD1B2F-9946-4C4B-B4DC-FE9904B8E05BQ37932076-6CB69E29-611C-41F0-AA0F-CA10F7FEEC09Q38055245-FC72F402-FAC5-405B-8D9A-FDC20C35137FQ41610251-6180AF50-E7DC-4F6F-8192-0D16442233B7Q42767818-2BB26FAE-54F5-476B-9B53-D496E6FFDEF8Q48185493-A9E90409-866C-4344-8C5E-CBC7482974E0Q53063504-F21E63D3-732D-41F2-B5D9-8CAC60E175BAQ53130761-0C8A6FB1-C7E1-4D89-A5D6-4817590D6818
P2860
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Postprandial hyperglycemia is ...... arly type 2 diabetes mellitus.
@en
Postprandial hyperglycemia is ...... arly type 2 diabetes mellitus.
@nl
type
label
Postprandial hyperglycemia is ...... arly type 2 diabetes mellitus.
@en
Postprandial hyperglycemia is ...... arly type 2 diabetes mellitus.
@nl
prefLabel
Postprandial hyperglycemia is ...... arly type 2 diabetes mellitus.
@en
Postprandial hyperglycemia is ...... arly type 2 diabetes mellitus.
@nl
P2093
P2860
P50
P1476
Postprandial hyperglycemia is ...... early type 2 diabetes mellitus
@en
P2093
G Ciabattoni
P Di Fulvio
P Sbraccia
P2860
P304
P356
10.1111/J.1538-7836.2010.03742.X
P577
2010-01-17T00:00:00Z